Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-4087

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68788-4087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

Image (Image 2)

FDA Label Image

Image (Image 3)

FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

FDA Label Image

Image (Image 6)

FDA Label Image

Image (Image 7)

FDA Label Image

Cyclobenzaprine HCl Er Capsules 15mg (Image 8)

Cyclobenzaprine HCl Er Capsules 15mg (Image 8)
This is a description of Cyclobenzaprine HCI ER Capsules which are extended-release capsules containing 15mg of Cyclobenzaprine HCI. It is a generic drug for Amrix, used for muscle relaxation. The capsules are orange in color and imprinted with "15mg." The medication should only be used by the patient for whom it was prescribed as federal law prohibits its transfer to others. It is advised to keep this medication out of the reach of children. The manufacturer is Teva Pharmaceuticals USA, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.